Pharmaceutical Potential of Selenium
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 December 2024 | Viewed by 62
Special Issue Editors
Interests: small-molecule nanoparticle; targeting drug delivery; nanomaterial-based immunoregulator
Special Issues, Collections and Topics in MDPI journals
Interests: tumor chemoradiotherapy; biomaterials and disease theranostics; signal transduction; oxidative stress and complex diseases
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; peptide-based nanoparticles; magnetic-propelled cell robots
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Selenium, an essential micronutrient, wields significant influence from its critical function in the maintenance of antioxidant defenses and redox status in cells to influencing immune responses and modulating disease processes. Therefore, selenium's varied biological activities enable its potential as a pleiotropic agent. Over the past years, selenium-based dietary supplements and pharmaceutical drugs have been widely investigated in different biology fields, such as cancer treatment and prevention, cardiovascular diseases, neurodegenerative disorders, and immune system enhancement. This Special Issue aims to explore the multifaceted roles of selenium, delving into its mechanisms of action at the molecular level and its therapeutic potential, including its incorporation into innovative drug delivery systems, which enhance the bioavailability and targeting efficiency. Potential authors are encouraged to submit contributions that offer new insights into selenium's biological activities, its clinical implications, and advancements in selenium-based drug delivery systems. Interdisciplinary studies that bridge the gap between basic research and clinical applications are particularly welcome.
Dr. Menghuan Tang
Dr. Cundong Fan
Dr. Zhaoqing Cong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pleiotropic selenium reagents
- drug delivery
- disease treatment and prevention
- selenium metabolism
- selenium toxicity
